Search results
This Menopause Side Effect Was Overlooked. Now Doctors Are Raising the Alarm
The Oprah Magazine· 7 days agoWomen are twice as likely to have an eating disorder in their 40s as to have breast cancer, but...
Why some cancers are diagnosed more frequently in higher-income populations
Indian Express· 3 days agoThis finding suggests a more intricate interplay between genetics, lifestyle factors, and access to...
Divisional commissioner directs NMC and ZP to conduct sewage audit in Nashik district | Nashik News...
The Times of India· 3 days agoNashik: Divisional commissioner Praveen Gedam on Monday directed the Nashik Municipal Corporation...
US Critical Materials, VerAI tie up on AI-driven mineral exploration
Mining Technology· 10 hours agoBy leveraging VerAI's AI technology, the companies anticipate a significant increase in the mineral...
UT to hold public hearing on waste management facility in Chandigarh | Chandigarh News - Times of...
The Times of India· 3 days agoChandigarh: The UT is all set to hold an open public hearing on the Integrated Solid Waste...
Industrial Commission delays decision on hiring next North Dakota oil regulator
North Dakota Monitor· 2 days agoThe Industrial Commission held off on picking North Dakota’s next top oil regulator for another week...
High Temps Aren't Just Bad For the Earth—They Affect Your Brain Too
Verywell Mind· 1 day agoThese strategies helped them manage their anxiety more effectively during the heatwave.” In fact, ...
New Study Reveals Condom, Lubricants Contain Toxic Chemicals Causing Infertility And Cancer
Times Now· 3 days agoIn what comes as a shocking development, a recent study has uncovered alarming levels of toxic PFAS chemicals in several well-known condoms and lubricants brands. The research
A different way to tackle scope 3 emissions - The Economic Times
The Economic Times· 15 hours agoThis reality means companies cannot credibly pledge to address their environmental impact without...
Zydus Lifes rises after receiving approval from COFEPRIS for Trastuzumab biosimilar
Business Standard India· 2 days agoZydus Lifesciences advanced 1.88% to Rs 1241.60 after the company announced the receipt of marketing approval for Mamitra, a Trastuzumab biosimilar, from the Mexican regulatory authority COFEPRIS.